ArticleFrontiers in cardiovascular medicine2026
A deep learning model for the interpretable identification of pulmonary thromboembolism from computed tomography pulmonary angiography.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: The rapid identification of pulmonary thromboembolism (PTE) on computed tomography pulmonary angiography (CTPA) is vital but labor-intensive, often leading to diagnostic delays. We aimed to construct and evaluate a YOLOv11 object detection algorithm capable of automatically highlighting intraluminal filling defects to expedite emergency radiological workflows. Methods: A retrospective analysis was conducted on CTPA scans from multiple centers. The dataset was divided into a primary internal cohort ( Results: During internal testing, the proposed framework yielded an AUC of 0.777 [95% confidence interval (CI): 0.765-0.788], corresponding to a sensitivity of 74.53% and a specificity of 64.26%. When applied to the external cohort, the algorithm's discriminative ability remained consistent with an AUC of 0.778 (95% CI: 0.749-0.806). Notably, the external sensitivity reached 86.75% (specificity: 54.46%). Visual assessments via Grad-CAM saliency maps confirmed that the model accurately localized embolic occlusions within the complex pulmonary arterial tree. Conclusion: Utilizing the YOLOv11 architecture for automated CTPA analysis yields a highly sensitive and visually interpretable screening mechanism. This artificial intelligence-assisted approach holds substantial promise for reducing missed diagnoses and accelerating patient triage in acute clinical settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.